#LCSM Chat Topic 4/6: Who Needs Research Anyway: How Have You Been Impacted by Lung Cancer Research?
Our topic for the next #LCSM Chat on Thursday, April 6th at 5 PM Pacific/ 8 PM Eastern is “Who Needs Research Anyway: How Have You Been Impacted by Lung Cancer Research?” The moderator for this chat is Dr. David Tom Cooke (@DavidCookeMD) In its most recent budget outline, the Trump administration is looking to propose an 18% cut to the National Institute of Health’s (NIH; @NIH) $31.7 billion budget (#trumpbudget). In addition to this funding cut, the Trump administration proposes to 1) reorganize the current NIH institute structure and 2)… Read More
#LCSM Chat Topic 3/23: What Is a High-Value Cancer Drug?
Our topic for the next #LCSM Chat on Thursday, March 23 at 5 PM Pacific (8 PM Eastern) will be “What Is a High-Value Cancer Drug?” With the price of new cancer drugs escalating, many are concerned about whether patients and the healthcare system can continue to access the most effective drugs. The 2016-2017 President’s Cancer Panel (PCP) topic is “Ensuring Patients’ Access to High-Value Cancer Drugs.” Andrew Schorr of Patient Power will be one of the patient advocates participating in the March 27, 2017 PCP meeting. This chat will help provide some inputs… Read More
#LCSM Chat Topic 3/9: Test Tumors to Target Lung Cancer
Our topic for the next #LCSM Chat on Thursday, March 9th at 5 PM Pacific (8 PM Eastern) is “Test Tumors to Target Lung Cancer.” Lung cancer treatments are evolving rapidly. Some newer treatments require testing to identify patients who are likely to respond to the drugs. The testing looks for certain biomarkers on the patient’s cancer tumors, like alterations in the tumor cells’ genes. Patients whose tumors test positive may be able to take approved targeted therapy drugs that are usually more effective and more tolerable than chemo. A substantial percentage… Read More
#LCSM 
You must be logged in to post a comment.